The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Northwest Biotherapeutics, Inc.

June 25, 2014 Levi & Korsinsky, LLP is investigating Northwest Biotherapeutics, Inc. (“Northwest Bio” or the “Company”) in connection with possible breaches of federal securities laws. The investigation regards concerns that the Company made misleading statements regarding its clinical trial for DC-Vax Direct, its experimental cancer vaccine. To get more information, click here: http://zlk.9nl.com/northwest-biotherapeutics-nwbo. There is no cost or obligation to …